Search Results - "Guerini‐Rocco, Elena"
-
1
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
Published in Cancer cell international (17-05-2021)“…The clinical outcome of patients with a diagnosis of hormone receptor (HR)+ breast cancer has improved remarkably since the arrival of endocrine therapy. Yet,…”
Get full text
Journal Article -
2
Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists
Published in Histopathology (01-02-2024)“…Many patients with non‐small cell lung cancer do not receive guideline‐recommended, biomarker‐directed therapy, despite the potential for improved clinical…”
Get full text
Journal Article -
3
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
Published in International journal of molecular sciences (01-06-2024)“…Multigene prognostic genomic assays have become indispensable in managing early breast cancer (EBC), offering crucial information for risk stratification and…”
Get full text
Journal Article -
4
A role for the immune system in advanced laryngeal cancer
Published in Scientific reports (27-10-2020)“…To investigate the role of the altered activation of the immune system in the prognosis of patients affected by laryngeal squamous cell carcinoma (LSCC). We…”
Get full text
Journal Article -
5
Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients
Published in Cancers (23-03-2022)“…The establishment of PARP inhibitors in the treatment of epithelial ovarian carcinoma (EOC) has prompt BRCA assessment at the time of diagnosis. We described…”
Get full text
Journal Article -
6
Whole‐exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast
Published in Histopathology (01-12-2019)“…Aims Acinic cell carcinoma (ACC) of the breast is a rare histological form of triple‐negative breast cancer (TNBC). Despite its unique histology, targeted…”
Get full text
Journal Article -
7
Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record
Published in Cancers (05-07-2020)“…A meeting among expert pathologists was held in 2019 in Rome to verify the results of the previous harmonization efforts on the PD-L1 immunohistochemical…”
Get full text
Journal Article -
8
The molecular landscape of breast mucoepidermoid carcinoma
Published in Cancer medicine (Malden, MA) (01-05-2023)“…Mucoepidermoid carcinoma (MEC) of the breast is an extremely rare salivary gland-type tumor characterized by epidermoid, basaloid, intermediate, and/or…”
Get full text
Journal Article -
9
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking
Published in Journal of personalized medicine (01-09-2023)“…Background. Biobanks are vital research infrastructures aiming to collect, process, store, and distribute biological specimens along with associated data in an…”
Get full text
Journal Article -
10
Successful treatment with avapritinib in patient with mucosal metastatic melanoma
Published in Therapeutic advances in medical oncology (01-07-2020)“…Metastatic vulvar melanoma is a rare and aggressive disease and survival is usually poor. Vulvar melanomas harbor BRAF V600 mutations only infrequently;…”
Get full text
Journal Article -
11
Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment
Published in Cancers (21-09-2021)“…Estrogen receptor (ER), progesterone receptor (PgR), Ki-67, and HER2 immunohistochemistry (IHC) together with HER2 in situ hybridization (ISH) are utilized to…”
Get full text
Journal Article -
12
Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter Study
Published in Diagnostics (Basel) (13-02-2022)“…The introduction of immunotherapy targeting the programmed death-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis has represented a turning point in the…”
Get full text
Journal Article -
13
Author Correction: A role for the immune system in advanced laryngeal cancer
Published in Scientific reports (03-05-2021)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
14
Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients
Published in Cells (Basel, Switzerland) (10-03-2021)“…We herein characterize the immunopathological features of two Italian COVID-19 patients who underwent bilateral lung transplantation (bLTx). Removed lungs…”
Get full text
Journal Article -
15
Contrast-Enhanced Computed Tomography Colonography in Preoperative Distinction between T1-T2 and T3-T4 Staging of Colon Cancer
Published in Academic radiology (01-05-2013)“…Rationale and Objectives To predict the T stage of nonrectal colon cancer using contrast-enhanced computed tomography colonography. Materials and Methods…”
Get full text
Journal Article -
16
E‐cadherin deregulation in breast cancer
Published in Journal of cellular and molecular medicine (01-06-2020)“…E‐cadherin protein (CDH1 gene) integrity is fundamental to the process of epithelial polarization and differentiation. Deregulation of the E‐cadherin function…”
Get full text
Journal Article -
17
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
Published in Genes (28-06-2020)“…Alterations in the tumor suppressor phosphatase and tensin homolog ( ) occur in a substantial proportion of solid tumors. These events drive tumorigenesis and…”
Get full text
Journal Article -
18
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
Published in Frontiers in molecular biosciences (15-03-2022)“…HER2 status in breast cancer is assessed to select patients eligible for targeted therapy with anti-HER2 therapies. According to the American Society of…”
Get full text
Journal Article -
19
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis
Published in The oncologist (Dayton, Ohio) (05-07-2024)“…Uterine leiomyosarcoma (uLMS) represents one of the most common sarcoma histotypes, demonstrating an overall dismal prognosis. Previous studies reported uLMS…”
Get full text
Journal Article -
20
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk
Published in Journal of clinical oncology (20-11-2015)“…The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in situ (LCIS) is poorly understood. Here, we review our 29-year longitudinal…”
Get full text
Journal Article